October 5, 2016: New collaboration to deliver complete solutions for industrial-scale bioreactor expansion of human Mesenchymal Stem/Stromal Cells (hMSCs), to accelerate product development, reduce clinical translation timelines and streamline the commercialization pathway for stem cell-based therapies

April 15, 2018: Patrnership to bring together Artesyn Biosolutions' valves and fluid handling technologies with Pall's Allegro solutions including bioreactors, range of downstream automated equipment and mixers to enable customers to implement efficient single-use manufacturing lines

December 13, 2017: Several recent and upcoming high-profile partnership announcements announced to help advance the drug production industry through key technology innovations

November 21, 2017: Introducing a new and robust solution for the economic clarification of mAb (monoclonal antibody) cell cultures without the need for centrifugation or process additives

Pall Medical takes the lead in patient care focus with hospital water filter US FDA 510K clearance for QPoint point-of-use filter.

Pall joins a consortium led by Oxford University in fast-tracking clinical trials for a COVID-19 vaccine beginning April 2020.

Feb 21, 2018: New centre to benefit students and the wider Biotech industry through direct access to the latest technologies including chromatography column packing and filter integrity testing apparatus

October 2, 2018: New centre will work to enhance drug production and empower the future workforce, reinforcing Pall's commitment to continuously improve bioprocesses through strategic partnerships

Press Releases from Pall.

December 18, 2018: New centre to give Pall customers options ranging from batch to single use and continuous bioprocessing solutions, and to provide technology solutions that meet current needs, while offering some of the most progressive technological solutions for the future

November 26, 2018: Cobra and Pall to make commercialisation of gene therapies safer, faster, and cheaper than ever before, help increase patient access to gene therapy and further establish best practices in manufacturing

March 11, 2019: Pall to integrate and distribute Broadley-James’ advanced single-use probe and flow cell pH sensors; sensor will be integrated into Pall single-use technologies

July 16, 2019: Servier chooses Pall as exclusive technology and services provider for planned Bio-S biomanufacturing facility in France

July 26, 2017: Announcing a new bioreactor control system - the first in Pall's next generation of unifying technologies for a seamless, fully controlled, and value-based user experience

November 14, 2017: New modules enable fully continuous processes in UF/DF processing steps, available in a range of size formats for use in one or more locations of a continuous mAb downstream purification process

September 25, 2017: Brammer Bio utilizes Pall's critical process solutions and process support, to help focus on building on more than 100 executed projects and 150 clinical cell and gene therapy lots in Florida, including many first-in-human trials

February 27, 2018: New offices, labs and manufacturing space for development and optimization of customer processes

September 3, 2018: Celltheon and Pall to provide an integrated, cost-effective, time efficient end-to-end solution for research and bioproduction to expedite drug development and provide solutions for unmet needs in bioprocessing

June 1, 2021: Precision NanoSystems (PNI) has been acquired by Danaher Corporation’s Life Sciences platform.

Pall has been working with healthcare professionals to design & produce filtration devices for infection prevention and cost containment. Read more.